Carlos Perezcano
Biographic Data
| ID | 4089563 |
|---|---|
| NAME | Carlos Perezcano |
| GIVEN NAMES | Carlos |
| FAMILY NAME | Perezcano |
| SIGNATURE | PEREZCANO C |
| AFFILIATIONS | ID Genomics (United States) |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
The critical need to implement pharmacogenomics in public health services
Adverse drug reactions (ADRs) are responsible for a significant proportion of hospitalizations globally, and represent a significant, yet partially preventable, burden on public health systems, particularly in resource-limited and low- and middle-income countries (LMICs), where chronic diseases and polypharmacy are highly prevalent. Pharmacogenomics (PGx), through targeted gene panels on drug-gene interactions, has shown potential to reduce ADRs,…
Apoe Genotype Distribution in a Mexican Population
The apolipoprotein E ( APOE ) ε4 allele is a major genetic risk factor for Alzheimer’s disease and cardio- vascular risk. This study analyzes the distribution of APOE alleles in 143 patients from a Mexican population based in Mexico City. The ε3 allele was the most prevalent (82.9%), followed by ε4 (12.5%) and ε2 (4.5%). Notably, the APOE 3/4 genotype, associated with increased risk for Alzheimer’s and cardiovascular disease, was observed in 21.0…
Apoe Genotype Distribution in a Mexican Population
The apolipoprotein E ( APOE ) ε4 allele is a major genetic risk factor for Alzheimer's disease and cardiovascular risk. This study analyzes the distribution of APOE alleles in 143 patients from a Mexican population based in Mexico City. The ε3 allele was the most prevalent (82.9%), followed by ε4 (12.5%) and ε2 (4.5%). Notably, the APOE 3/4 genotype, associated with increased risk for Alzheimer's and cardiovascular disease, was observed in 21.0% …
No prominent works on this page.
Apoe Genotype Distribution in a Mexican Population
The apolipoprotein E ( APOE ) ε4 allele is a major genetic risk factor for Alzheimer's disease and cardiovascular risk. This study analyzes the distribution of APOE alleles in 143 patients from a Mexican population based in Mexico City. The ε3 allele was the most prevalent (82.9%), followed by ε4 (12.5%) and ε2 (4.5%). Notably, the APOE 3/4 genotype, associated with increased risk for Alzheimer's and cardiovascular disease, was observed in 21.0% …
Apoe Genotype Distribution in a Mexican Population
The apolipoprotein E ( APOE ) ε4 allele is a major genetic risk factor for Alzheimer’s disease and cardio- vascular risk. This study analyzes the distribution of APOE alleles in 143 patients from a Mexican population based in Mexico City. The ε3 allele was the most prevalent (82.9%), followed by ε4 (12.5%) and ε2 (4.5%). Notably, the APOE 3/4 genotype, associated with increased risk for Alzheimer’s and cardiovascular disease, was observed in 21.0…
The critical need to implement pharmacogenomics in public health services
Adverse drug reactions (ADRs) are responsible for a significant proportion of hospitalizations globally, and represent a significant, yet partially preventable, burden on public health systems, particularly in resource-limited and low- and middle-income countries (LMICs), where chronic diseases and polypharmacy are highly prevalent. Pharmacogenomics (PGx), through targeted gene panels on drug-gene interactions, has shown potential to reduce ADRs,…
Genetic Associations and Epidemiology (1 work) · Genomics and Rare Diseases (1 work) · Global health (1 work) · Health care (1 work) · Health Policy (1 work) · Medical prescription (1 work) · Pharmacogenetics and Drug Metabolism (1 work) · Pharmacogenomics (1 work) · Polypharmacy (1 work) · Public health (1 work)